Epidemiology of sepsis in pediatric intensive care units: first Colombian multicenter study

Juan C Jaramillo-Bustamante1, Alejandro Marín-Agudelo, Mauricio Fernández-Laverde

  • 1From the CES University (JCJ-B, AM-A, MF-L), Pediatric Intensive Care Program, Medellín, Colombia. juancajara@sepsisencolombia.com

Insights

Sepsis is a significant concern in Colombian pediatric intensive care units, affecting many young children. Key risk factors for mortality include young age, shock, organ dysfunction, and Gram-negative bacteria infections.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Epidemiology

Background:

  • Sepsis is a leading cause of death with substantial economic and social costs.
  • Limited epidemiologic data exists for pediatric sepsis, particularly in Colombia.
  • The Surviving Sepsis Campaign highlighted the need for increased awareness and research.

Purpose of the Study:

  • To describe the sociodemographic and clinical characteristics of pediatric sepsis patients in Colombia.
  • To identify risk factors associated with sepsis and its outcomes in a pediatric intensive care setting.
  • To provide crucial epidemiologic data on pediatric sepsis in a developing country context.

Main Methods:

  • A prospective study was conducted across 19 pediatric intensive care units in Colombia.
  • Data was collected via a dedicated website (sepsisencolombia.com) over a one-year period (March 2009-February 2010).
  • Sociodemographic and clinical data of 1,051 pediatric sepsis patients were analyzed.

Main Results:

  • 1,051 pediatric patients were included; 55% were male, 56% were under 2 years old, and 76% from low socioeconomic strata.
  • Sepsis, severe sepsis, and septic shock affected 27%, 25%, and 48% of patients, respectively. Multiple organ dysfunction syndrome was present in 43%.
  • Respiratory infections were the most common source (54%). Gram-negative bacteria were frequent etiological agents with high mortality. Overall mortality was 18%, with younger age, shock, organ dysfunction, and Gram-negative bacteria as significant risk factors.

Conclusions:

  • Sepsis is a prevalent condition in Colombian pediatric intensive care units.
  • Specific risk factors for sepsis acquisition and mortality have been identified.
  • The considerable mortality rate underscores the significant public health challenge sepsis poses in developing societies.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...